Matthew R. Cooperberg

Nov 20, 2024 | jamanetwork.com | Stacy Loeb |Matthew R. Cooperberg |William Catalona

Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020 Active surveillance and watchful waiting, periods of observation rather than early treatment, are considered optimal initial management strategies for individuals with nonaggressive prostate cancer.1 A recent surveillance study found low risks of metastasis (1.4%) and cancer mortality (0.1%) with active surveillance in individuals with primarily low–risk prostate cancer, typically defined as the lowest...

Nov 4, 2024 | nature.com | Matthew R. Cooperberg

Literature about prostate cancer in transgender women is growing, but many questions remain unanswered. Unique challenges exist in the identification of transgender women that can slow or even impair research advances in this field. Reframing our thinking about the identification of this population is imperative to help advance both research and clinical care.

Jun 18, 2024 | europeanurology.com | Matthew R. Cooperberg

Active surveillance (AS) is now the preferred standard of care, endorsed by major guidelines for management of low-risk prostate cancers [ 1 Cornford P, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer—2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.03.027. , 2 Eastham J.A. Auffenberg G.B. Barocas D.A. et al.

Apr 10, 2024 | nature.com | Sriram Deivasigamani |Joshua Parrish |William J. Aronson |Christopher Kane |Martha K. Terris |Lourdes Guerrios-Rivera | +3 more

AbstractCertain widely used pathological outcome prediction models that were developed in tertiary centers tend to overpredict outcomes in the community setting; thus, the Michigan Urological-Surgery Improvement Collaborative (MUSIC) model was developed in general urology practice to address this issue. Additionally, the development of these models involved a relatively small proportion of Black men, potentially compromising the accuracy of predictions in this patient group.

Jan 25, 2024 | europeanurology.com | Andrew J. Vickers |Melissa Assel |Matthew R. Cooperberg

To read this article in full you will need to make a paymentSubscribe to European UrologyReferencesThree things about Gleason grading that just about everyone believes but that are almost certainly wrong. Urology. 143: 16-19Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?. Am J Surg Pathol. 36: 1346-1352Clinical usefulness of total length of Gleason pattern 4 on biopsy in men with grade group 2 prostate cancer. J Urol.